These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9682905)

  • 1. Two brain inhibitors inhibit renal Na,K-ATPases without recognizing the species-dependent variation of their ouabain-sensitivity.
    Anner BM
    Clin Exp Hypertens; 1998; 20(5-6):489-97. PubMed ID: 9682905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
    Pôças ES; Costa PR; da Silva AJ; Noël F
    Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal sensitivity of Na+/K(+)-ATPase isolated from brain and kidney of spontaneously hypertensive rats to sodium, ouabain or mercury.
    Anner BM; Imesch E; Moosmayer M
    Biochim Biophys Acta; 1995 Jan; 1270(1):95-9. PubMed ID: 7827142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium transport defect of ouabain-resistant renal Na,K-ATPase.
    Anner BM; Imesch E; Moosmayer M
    Biochem Biophys Res Commun; 1989 Nov; 165(1):360-7. PubMed ID: 2556141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric method for the determination of renal ouabain-sensitive H+,K+-ATPase activity.
    Bełtowski J; Wójcicka G
    Acta Biochim Pol; 2002; 49(2):515-27. PubMed ID: 12362994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of renal Na(+),K(+)-ATPase and ouabain-sensitive H(+),K(+)-ATPase by the cyclic AMP-protein kinase A signal transduction pathway.
    Bełtowski J; Marciniak A; Wójcicka G; Górny D
    Acta Biochim Pol; 2003; 50(1):103-14. PubMed ID: 12673350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
    Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
    Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl sulfoxide inhibits renal Na(+)-K(+)-ATPase at a site different from ouabain and atrial peptides.
    Chiou S; Vesely DL
    Life Sci; 1995; 57(10):945-55. PubMed ID: 7643719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrophotometric assay of renal ouabain-resistant Na(+)-ATPase and its regulation by leptin and dietary-induced obesity.
    Bełtowski J; Jamroz-Wiśniewska A; Nazar J; Wójcicka G
    Acta Biochim Pol; 2004; 51(4):1003-14. PubMed ID: 15625572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.
    Mujais SK; Chekal MA; Jones WJ; Hayslett JP; Katz AI
    J Clin Invest; 1985 Jul; 76(1):170-6. PubMed ID: 2991336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Na+,K+-ATPase isozyme activity and protein expression in ouabain-induced hypertension.
    Kent MA; Huang BS; Van Huysse JW; Leenen FH
    Brain Res; 2004 Aug; 1018(2):171-80. PubMed ID: 15276875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Na+]i/[K+]i -independent death of ouabain-treated renal epithelial cells is not mediated by Na+,K+ -ATPase internalization and de novo gene expression.
    Akimova OA; Hamet P; Orlov SN
    Pflugers Arch; 2008 Jan; 455(4):711-9. PubMed ID: 17622553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
    Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
    Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid-induced modulation of ouabain responsiveness of rat Na, K-ATPase isoforms.
    Gerbi A; Maixent JM
    J Membr Biol; 1999 Mar; 168(1):19-27. PubMed ID: 10051686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine triphosphatases of rat pancreatic islets: comparison with those of rat kidney.
    Levin SR; Kasson BG; Driessen JF
    J Clin Invest; 1978 Sep; 62(3):692-701. PubMed ID: 211146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
    Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
    Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.